KAYLA WISSING: Open Payments
NPI 1811620818 · PENSACOLA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$420 in 14 payments from 8 companies in 2025. Trend: 2023 $471 · 2024 $790 · 2025 $420
Food & beverage: $420
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $134 |
| Amgen Inc. | 1 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ABBVIE INC. | 2 | $46 |
| Astellas Pharma US Inc | 2 | $44 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Medtronic, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: Ozempic, EVENITY, AIRSUPRA, Veozah, Wegovy, UBRELVY, XIFAXAN, MINIMED 780G.
Industry payments across FL — which companies pay providers there.
